Survodutide vs ARA-290 | Research Comparison | QSC

Survodutide vs ARA-290

Mechanism, clinical data, and research applications

Shop Both at QSC →

Factor Survodutide Ara 290
Receptors GLP-1R + GCGR IRR agonist (neuropathy)
Best Trial Result Phase 2 NASH data Phase 2 neuropathy data
At QSC ✓ In Stock ✓ In Stock
Analysis: Different mechanisms and indications — survodutide is metabolic; ARA-290 is neuropathic. Both QSC first-movers.
Research Use Only.
Peptides
Orals
Oils
Search
Contact